Silihan lan utang jangka dawa perusahaan: synergychc.com (SNYR)

Logo perusahaan publik Synergy CHC (SNYR)

This chart of Synergy CHC Corp (SNYR) trading on the GURU.Markets platform demonstrates long-term debt, which stands at 0.00. The holding's capitalization relies on the sale of cosmetics and dietary supplements through online stores. Amid intense competition, Synergy CHS Corp (SNYR) is scaling its reach through active social media promotion. Creative marketing teams, motivated by a bonus system for increasing brand profits, drive the business development.

SNYR Utang jangka dawa perusahaan Synergy CHC Corp. (24.10.2024 - 03.10.2026)
Produk merek synergychc.com

Investors must evaluate the aggregate of long-term liabilities, which measure the sustainability of financial leverage and the risk of default should cash flow decline. An analysis of the company's long-term debt allows for a comparison between the pace of credit growth and the declining marketing efficiency of Synergy CHC Corp (SNYR), where falling sales of health brands may limit the company's ability to service its accumulated liabilities.

Karo sapa Synergy CHC Corp saingan

Utang jangka dawa perusahaan haleon.com HLN|KVUE - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Ligand Corp|AMRX (Amneal Pharmaceuticals) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan perrigo.com|Kewajiban jangka dawa perusahaan ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Utang jangka dawa|MNKD: Kewajiban jangka dawa perusahaan|amphastar.com - Gedhene kewajiban jangka dawa|PCRX: Utang jangka dawa perusahaan|ARS Pharmaceuticals Inc - Silihan lan utang jangka dawa perusahaan|TBPH (Theravance) - Utang jangka dawa perusahaan|Utang jangka dawa Aquestive Corp AQST|Utang jangka dawa perusahaan scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Tonix Pharmaceuticals Holding Corp. TNXP|Gunggunge utang jangka dawa SXT Pharmaceuticals (SXTC)|EPRX: Kewajiban jangka dawa perusahaan|Utang jangka dawa BioHarvest Sciences Inc|eXoZymes Inc (EXOZ) - Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan ORMP|ENTX (Entera Bio Ltd) - Utang jangka dawa perusahaan|Utang jangka dawa MindWalk Holdings, Inc. HYFT|Utang jangka dawa perusahaan ABVC BioPharma Inc (ABVC)|CPIX (Cumberland Corp) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan QNTM (Quantum BioPharma Ltd)|Tanggungan jangka dawa fibrogen.com|TELO: Kewajiban jangka dawa perusahaan|Utang jangka dawa Rani Therapeutics|RLYB (rallybio.com) - Kewajiban jangka dawa perusahaan|Lexaria Bioscience Corp. - Silihan lan utang jangka dawa perusahaan|PULM (Pulmatrix, Inc.) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Pheton (PTHL)|Utang jangka dawa perusahaan APM|LYRA (Lyra Therapeutics Inc.) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan IBO (Impact BioMedical Inc)|TNFA - Kewajiban jangka dawa perusahaan|YCBD: Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan PRFX (painreform.com)|CYTO: Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Lipella Pharmaceuticals Inc|Utang jangka dawa perusahaan Optinose|Utang jangka dawa Pieris Pharma PIRS|Utang jangka dawa perusahaan Procaps Group S.A. (PROC)|PTPI (petrospharma.com) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Qilian International Holding QLI|SLRN (Acelyrin Inc.) - Kewajiban jangka dawa|TFFP - Utang jangka dawa perusahaan